Endometriosis. Endometriosis, unspecified
Conditions
Interventions
Intervention 1: Intervention group:The 10 mg of melatonin with Gelofen tablet. Intervention 2: Comparison group:
Plasebo with gelofen tablets.
Treatment - Drugs
Intervention group:The 10 mg of melatonin with Gelofen tablet
Comparison group:
Plasebo with gelofen tablets
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: A definitive diagnosis of endometriosis, menstrual cycle within 21-35 days; age 18-45 years, who have 5 or more based on pain intensity of at least 3 months and up to one year past their surgery is a non-hormonal drugs within three previous month. Exclusion Criteria: During the last 3 months of hormonal treatment received, history of liver disease, kidney disease, severe anemia history of carcinoma; questionnaires based on their preoperative pain intensity, pain is less than 5, a history of diabetes, taking anti-clotting medication.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 8 and 12 weeks after treatment. Method of measurement: Visual analog score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Sepideh Khodaverdi
Iran University of Medical Science
Outcome results
None listed